L
62
2
M
20
-4
INTU
51
2
DE
46
3
DHR
35
3
EL
20
3
COP
56
2
COF
55
-3
TRV
53
-3
CMCSA
48
2
DD
56
3
MTCH
37
7
EQR
54
-2
URI
53
-2
EFX
32
2
XEL
67
2
LB
34
8
JWN
40
-2
PCG
93
2
V
60
-6
L
62
2
M
20
-4
INTU
51
2
DE
46
3
DHR
35
3
EL
20
3
COP
56
2
COF
55
-3
TRV
53
-3
CMCSA
48
2
DD
56
3
MTCH
37
7
EQR
54
-2
URI
53
-2
EFX
32
2
XEL
67
2
LB
34
8
JWN
40
-2
PCG
93
2
V
60
-6
Financhill
Back

Aurora Cannabis 10K Form

Sell
26

ACB
Aurora Cannabis

Last Price:
4.28
Seasonality Move:
7.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACB News And Ratings

See the #1 stock for the next 7 days that we like better than ACB

ACB Financial Statistics

Sales & Book Value

Annual Sales: $200.33M
Cash Flow: $-21.56M
Price / Cash Flow: 0
Annual Sales: $7.33
Price / Book: 0.58

Profitability

EPS (TTM): -0.67010
Net Income (TTM): $-34.96M
Gross Margin: $97.44M
Return on Equity: -8.16%
Return on Assets: -5.73%

Aurora Cannabis Earnings Forecast

Key Aurora Cannabis Financial Ratios

  • The Gross Profit Margin over the past 17 years for ACB is 48.64%.
  • The Selling, General & Administrative Expenses for ACB have been equal to 58.04% of Gross Profit Margin.
  • The Research & Development expenses have been 1.32% of Revenue.
  • The Interest Expense is -20.46% of Operating Income.
  • The Net Earning history of ACB is -25.65% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

Aurora Cannabis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ACB
CUSIP: 05156X
Website: auroramj.com

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 3.83
Quick Ratio: 1.15

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACB Technical Analysis vs Fundamental Analysis

Sell
26
Aurora Cannabis (ACB) is a Sell

Is Aurora Cannabis a Buy or a Sell?

  • Aurora Cannabis stock is rated a Sell
    The current Aurora Cannabis [ACB] share price is $4.24. The Score for ACB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.